Related Experiment Video
Updated: Aug 8, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease
Abdulla A Damluji1, Nikhil R Gangasani2, Cindy L Grines2
1Johns Hopkins University School of Medicine, 1800 Orleans Street, Baltimore, MD 21287, USA; Inova Center of Outcomes Research, 3300 Gallows Road, Falls Church, VA 22042, USA.
Insights
COVID-19 can cause severe cardiac injury, leading to acute myocardial infarction (AMI) and potentially fatal mechanical complications. Prompt recognition and treatment are crucial for improving outcomes in these high-risk patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19's inflammatory response can cause significant cardiac injury, including acute myocardial infarction (AMI).
- Mechanical complications of AMI, such as cardiogenic shock, pose a severe threat to patient survival.
- Late presentation post-infarct increases the risk of these dire complications.
Purpose of the Study:
- To highlight the link between COVID-19 and cardiac complications.
- To emphasize the critical nature of mechanical complications following myocardial infarction.
- To underscore the importance of timely diagnosis and intervention.
Main Methods:
- Review of clinical data and outcomes for patients with COVID-19 and cardiac injury.
- Analysis of factors contributing to mechanical complications post-myocardial infarction.
- Evaluation of treatment strategies and their impact on patient prognosis.
Main Results:
- COVID-19 is associated with increased incidence of cardiac injury and AMI.
- Delayed treatment of AMI in COVID-19 patients elevates the risk of mechanical complications and cardiogenic shock.
- Poor outcomes are observed in patients with untreated or delayed-treated mechanical complications.
Conclusions:
- Aggressive COVID-19 inflammation poses a significant threat to cardiac health.
- Mechanical complications of AMI, especially in the context of COVID-19, require urgent recognition and management.
- Prompt therapeutic interventions are vital to mitigate mortality and morbidity associated with these severe cardiac events.
Abstract:
The aggressive inflammatory response to COVID-19 can result in airway damage, respiratory failure, cardiac injury, and multiorgan failure, which lead to death in susceptible patients. Cardiac injury and acute myocardial infarction (AMI) secondary to COVID-19 disease can lead to hospitalization, heart failure, and sudden cardiac death. When serious collateral damage from tissue necrosis or bleeding occurs, mechanical complications of myocardial infarction and cardiogenic shock can ensue. While prompt reperfusion therapies have decreased the incidence of these serious complications, patients who present late following the initial infarct are at increased for mechanical complications, cardiogenic shock, and death. The health outcomes for patients with mechanical complications are dismal if not recognized and treated promptly. Even if they survive serious pump failure, their CICU stay is often prolonged, and their index hospitalization and follow-up visits may consume significant resources and impact the health care system.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction
Myocarditis III: Medical Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care

